Having a thorough
understanding of the infectivity of HIV, time of initiating treatment and
emergence of drug resistant virus variants is crucial in mitigating HIV
infection. There are many challenges to evaluating the long-term effect of the
Highly Active Antiretroviral Therapy (HAART) on disease transmission at the
population level. We proposed an individual based model by coupling within-host
dynamics and between-host dynamics and conduct stochastic simulation in the
group of men who have sex with men (MSM). The mean actual reproduction number
is estimated to be 3.6320 (95% confidence interval: [3.46, 3.80]) for MSM group
without treatment. Stochastic simulations show that given relatively high (low)
level of drug efficacy after emergence of drug resistant variants, early
initiation of treatment leads to a less (greater) actual reproduction number,
lower (higher) prevalence and less (more) incidences, compared to late
initiation of treatment. This implies early initiation of HAART may not always
lower the actual reproduction number and prevalence of infection, depending on
the level of treatment efficacy after emergence of drug resistant virus
variants, frequency of high-risk behaviors and etc. This finding strongly
suggests early initiation of HAART should be implemented with great care
especially in the settings where the effective drugs are limited. Coupling within-host
dynamics with between-host dynamics can provide critical information about
impact of HAART on disease transmission and thus help to assist treatment
strategy design and HIV/AIDS prevention and control.
Below: Time series of susceptible and infected individuals
Below: Histogram of the number of secondary cases induced by a single infected individual in a simulation
Full article at: http://goo.gl/MHsHUH
By: Xiaodan
Sun,1 Yanni Xiao,1,* Sanyi Tang,2 Zhihang
Peng,3 Jianhong
Wu,4 and Ning Wang5,*
Gui-Quan Sun, Editor
1Department of Applied Mathematics, Xi’an
Jiaotong University, Xi’an, Shaanxi, China
2College of Mathematics and Information
Science, Shaanxi Normal University, Xi’an, Shaanxi, China
3School of Public Health, Nanjing Medical
University, Nanjing, Jiangsu, China
4Laboratory for Industrial and Applied
Mathematics, Centre for Disease Modelling, York Institute for Health Research,
York University, Toronto, ON, Canada
5National Center for AIDS/STD Prevention
and Control, Chinese Center for Disease Control and Prevention, Beijing, China
Shanxi
University, CHINA
More at: https://twitter.com/hiv insight
No comments:
Post a Comment